Doina Ganea

17.3k total citations
162 papers, 9.1k citations indexed

About

Doina Ganea is a scholar working on Cellular and Molecular Neuroscience, Immunology and Oncology. According to data from OpenAlex, Doina Ganea has authored 162 papers receiving a total of 9.1k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Cellular and Molecular Neuroscience, 66 papers in Immunology and 42 papers in Oncology. Recurrent topics in Doina Ganea's work include Neuropeptides and Animal Physiology (78 papers), Immunotherapy and Immune Responses (28 papers) and Immune Response and Inflammation (24 papers). Doina Ganea is often cited by papers focused on Neuropeptides and Animal Physiology (78 papers), Immunotherapy and Immune Responses (28 papers) and Immune Response and Inflammation (24 papers). Doina Ganea collaborates with scholars based in United States, Spain and Belarus. Doina Ganea's co-authors include Mario Delgado, Jui‐Hung Yen, Rosa P. Gomariz, David Pozo, Javier Leceta, Elena González‐Rey, Carmen Martínez, Huie Jing, Weimin Kong and Ernesto J. Muñoz‐Elías and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Doina Ganea

161 papers receiving 8.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Doina Ganea United States 62 4.1k 2.8k 2.5k 1.6k 1.2k 162 9.1k
Mario Delgado Spain 70 6.0k 1.4× 3.1k 1.1× 3.7k 1.5× 2.4k 1.6× 2.7k 2.2× 210 13.6k
Rosa P. Gomariz Spain 43 3.5k 0.8× 1.5k 0.5× 1.5k 0.6× 1.3k 0.8× 1.1k 0.9× 125 5.9k
Thomas J. Rogers United States 50 2.4k 0.6× 1.7k 0.6× 3.2k 1.3× 1.2k 0.7× 305 0.2× 184 7.8k
Elena González‐Rey Spain 42 1.4k 0.3× 1.6k 0.6× 1.5k 0.6× 928 0.6× 1.1k 0.9× 106 6.2k
Celia F. Brosnan United States 70 2.6k 0.6× 6.3k 2.3× 4.7k 1.8× 1.9k 1.2× 330 0.3× 205 16.7k
Klaus V. Toyka Germany 66 4.4k 1.1× 2.2k 0.8× 2.9k 1.1× 771 0.5× 616 0.5× 202 12.7k
Charles D. Mills United States 37 1.0k 0.2× 3.6k 1.3× 2.2k 0.9× 908 0.6× 1.1k 0.9× 61 8.6k
Shuxian Hu United States 52 1.4k 0.3× 2.0k 0.7× 1.7k 0.7× 402 0.3× 349 0.3× 140 7.7k
Francesca Aloisi Italy 62 2.1k 0.5× 6.7k 2.4× 3.2k 1.3× 2.5k 1.6× 330 0.3× 130 15.9k
Akio Suzumura Japan 62 2.3k 0.6× 3.6k 1.3× 3.4k 1.3× 759 0.5× 443 0.4× 192 11.9k

Countries citing papers authored by Doina Ganea

Since Specialization
Citations

This map shows the geographic impact of Doina Ganea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Doina Ganea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Doina Ganea more than expected).

Fields of papers citing papers by Doina Ganea

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Doina Ganea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Doina Ganea. The network helps show where Doina Ganea may publish in the future.

Co-authorship network of co-authors of Doina Ganea

This figure shows the co-authorship network connecting the top 25 collaborators of Doina Ganea. A scholar is included among the top collaborators of Doina Ganea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Doina Ganea. Doina Ganea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Yen, Jui‐Hung, et al.. (2017). Prostaglandin E2 Inhibition of IL-27 Production in Murine Dendritic Cells: A Novel Mechanism That Involves IRF1. PMC. 1 indexed citations
3.
Adhikary, Sabina, Hongbo Li, Joshua Heller, et al.. (2011). Modulation of Inflammatory Responses by a Cannabinoid-2–Selective Agonist after Spinal Cord Injury. Journal of Neurotrauma. 28(12). 2417–2427. 61 indexed citations
4.
Yen, Jui‐Hung, Weimin Kong, & Doina Ganea. (2010). IFN-β Inhibits Dendritic Cell Migration through STAT-1–Mediated Transcriptional Suppression of CCR7 and Matrix Metalloproteinase 9. The Journal of Immunology. 184(7). 3478–3486. 60 indexed citations
5.
Khayrullina, Tanzilya, Jui‐Hung Yen, Huie Jing, & Doina Ganea. (2008). In Vitro Differentiation of Dendritic Cells in the Presence of Prostaglandin E2 Alters the IL-12/IL-23 Balance and Promotes Differentiation of Th17 Cells. The Journal of Immunology. 181(1). 721–735. 139 indexed citations
6.
González‐Rey, Elena, et al.. (2006). Cortistatin, an antiinflammatory peptide with therapeutic action in inflammatory bowel disease. Proceedings of the National Academy of Sciences. 103(11). 4228–4233. 95 indexed citations
7.
Sharma, Vikas, Mario Delgado, & Doina Ganea. (2006). Granzyme B, a New Player in Activation-Induced Cell Death, Is Down-Regulated by Vasoactive Intestinal Peptide in Th2 but Not Th1 Effectors. The Journal of Immunology. 176(1). 97–110. 54 indexed citations
8.
Delgado, Mario, Elena González‐Rey, & Doina Ganea. (2005). The Neuropeptide Vasoactive Intestinal Peptide Generates Tolerogenic Dendritic Cells. The Journal of Immunology. 175(11). 7311–7324. 114 indexed citations
9.
Delgado, Mario & Doina Ganea. (2003). Vasoactive intestinal peptide inhibits IL-8 production in human monocytes. Biochemical and Biophysical Research Communications. 301(4). 825–832. 28 indexed citations
10.
Kim, Woong‐Ki, Doina Ganea, & G. Miller Jonakait. (2002). Inhibition of microglial CD40 expression by pituitary adenylate cyclase-activating polypeptide is mediated by interleukin-10. Journal of Neuroimmunology. 126(1-2). 16–24. 28 indexed citations
13.
Delgado, Mario & Doina Ganea. (2001). Cutting Edge: Is Vasoactive Intestinal Peptide a Type 2 Cytokine?. The Journal of Immunology. 166(5). 2907–2912. 79 indexed citations
14.
Delgado, Mario & Doina Ganea. (2001). Inhibition of Endotoxin-Induced Macrophage Chemokine Production by VIP and PACAP In Vitro and In Vivo. Archives of Physiology and Biochemistry. 109(4). 377–382. 36 indexed citations
15.
Delgado, Mario & Doina Ganea. (2000). Inhibition of IFN-γ-Induced Janus Kinase-1-STAT1 Activation in Macrophages by Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-Activating Polypeptide. The Journal of Immunology. 165(6). 3051–3057. 66 indexed citations
17.
Delgado, Mario, Carmen Martínez, David Pozo, et al.. (1999). Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activation polypeptide (PACAP) protect mice from lethal endotoxemia through the inhibition of TNF-alpha and IL-6.. PubMed. 162(2). 1200–5. 178 indexed citations
18.
Ganea, Doina, Peter Moore, Lavanya Chekuri, & Raju Kucherlapati. (1987). Characterization of an ATP-Dependent DNA Strand Transferase from Human Cells. Molecular and Cellular Biology. 7(9). 3124–3130. 19 indexed citations
19.
Ayares, David, Doina Ganea, Lavanya Chekuri, Colin Campbell, & Raju Kucherlapati. (1987). Repair of Single-Stranded DNA Nicks, Gaps, and Loops in Mammalian Cells. Molecular and Cellular Biology. 7(5). 1656–1662. 13 indexed citations
20.
Dumitrescu, A, et al.. (1975). [Preparation of alpha 2 macroblobulin from the placenta and human retroplacental blood].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 34(1-2). 91–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026